PRA Health Sciences (PRAH) Tops Q3 EPS by 6c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Apple seeks to raise up to $7 billion in seven-tranche bond offering
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- SanDisk shares fall on election and chip sector pressure
- Seagate Technology shares drop amid sector selloff
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
PRA Health Sciences, Inc. Reports Third Quarter 2018 Results and Updates 2018 Guidance
October 31, 2018 4:40 PM EDTNet new business of $657.2 million; Net book-to-bill of 1.28
$717.6 million of revenue; 23.3% growth at actual foreign exchange rates and 24.0% growth on a constant currency basis
$572.9 million of revenue excluding the impact of ASC 606; 15.8% growth at actual foreign exchange rates; 16.3% growth on a constant currency basis
GAAP net income per diluted share of $0.02 and GAAP net income of $1.5 million
Adjusted net income per diluted share was $1.13 and adjusted net income was $74.8 million
Maintaining 2018 revenue guidance between... More



